The role of glypican-3 in the regulation of body size and cancer, Cell Cycle, vol.7, pp.2787-2790, 2008. ,
Glypicans: proteoglycans with a surprise, J. Clin. Invest, vol.108, pp.497-501, 2001. ,
Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma, Exp. Mol. Pathol, vol.82, pp.184-189, 2007. ,
Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma, Anti-Cancer Agents Med. Chem, vol.11, pp.543-548, 2011. ,
Glypican-3: a new target for cancer immunotherapy, Eur. J. Cancer, vol.47, pp.333-338, 2011. ,
Fine-tuning of cell signaling by glypicans, Cell. Mol. Life Sci, vol.68, pp.923-929, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00202709
Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development, Histol. Histopathol, vol.23, pp.1333-1340, 2008. ,
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution, Cancer Res, vol.57, pp.5179-5184, 1997. ,
Cloning and expression of MXR7 gene in human HCC tissue, World J. Gastroenterol, vol.6, pp.57-60, 2000. ,
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders, Gut, vol.48, pp.558-564, 2001. ,
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling, Int. J. Cancer, vol.103, pp.455-465, 2003. ,
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1, Nat. Genet, vol.24, pp.245-250, 2000. ,
Structure of the protein core of the glypican Dallylike and localization of a region important for hedgehog signaling, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.13112-13117, 2011. ,
Genetic mechanisms of hepatocarcinogenesis, Oncogene, vol.21, pp.2593-2604, 2002. ,
WNT/betacatenin signaling in liver health and disease, Hepatology, vol.45, pp.1298-1305, 2007. ,
, , 2015.
, Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma, Hepatobiliary Pancreatic Dis. Int, vol.14, pp.361-366
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma, Oncotarget, vol.7, pp.69916-69926, 2016. ,
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma, World J. Gastroenterol, vol.22, pp.275-283, 2016. ,
Advances in targeted therapies for hepatocellular carcinoma in the genomic era, Nat. Rev. Clin. Oncol, vol.12, pp.408-424, 2015. ,
Crystal structure of N-glycosylated human glypican-1 core protein: structure of two loops evolutionarily conserved in vertebrate glypican-1, J. Biol. Chem, vol.287, pp.14040-14051, 2012. ,
Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements, J. Cell Biol, vol.163, pp.625-635, 2003. ,
Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth, J. Biol. Chem, vol.280, pp.41201-41206, 2005. ,
, , 2005.
, Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling, Cancer Res, vol.65, pp.6245-6254
Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo, Int. J. Cancer, vol.126, pp.1291-1301, 2010. ,
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro, Int. J. Cancer, vol.128, pp.2246-2247, 2011. ,
A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma, Hepatology, vol.57, pp.195-204, 2013. ,
Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method, Mol. Cell. Proteomics, vol.8, pp.1777-1788, 2009. ,
How to measure and predict the molar absorption coefficient of a protein, Protein Sci, vol.4, pp.2411-2423, 1995. ,
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma, Cancer Res, vol.64, pp.2418-2423, 2004. ,
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.8847-8851, 1998. ,
Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway, Int. J. Oncol, vol.46, pp.1275-1285, 2015. ,
Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells, Mol. Med. Rep, vol.10, pp.3177-3184, 2014. ,
Pyroglutamic acid: throwing light on a lightly studied metabolite, Curr. Sci, vol.102, pp.288-297, 2012. ,
Protein aminoterminal modifications and proteomic approaches for N-terminal profiling, Curr. Opin. Chem. Biol, vol.24, pp.71-79, 2015. ,
Product quality considerations for mammalian cell culture process development and manufacturing, Adv. Biochem. Eng./Biotechnol, vol.139, pp.123-166, 2013. ,
Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells, Cancer Res, vol.61, pp.5562-5569, 2001. ,
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer, BMC Cancer, vol.13, p.24, 2013. ,
Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model, Breast Cancer Res. Treat, vol.80, pp.221-232, 2003. ,
Glypican-3 expression is silenced in human breast cancer, Oncogene, vol.20, pp.7408-7412, 2001. ,
Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling, J. Biol. Chem, vol.290, pp.7576-7585, 2015. ,